CRI Carters (CRI) Insider Trading, Ownership & Congress Trades
Consumer Goods · Apparel & other finishd prods of fabrics & similar matl · CIK 0001060822
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
151
13F, latest reported quarter
Carters insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for CARTERS INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 25, 2023.
- The trade is 3.0% of the 35,173 shares held after it.
- 1 other insider sold within 30 days.
- 151 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP Global Marketing Jenkins Jeff sold about $91.2K of CRI on Mar 13, 2024; 1 other insider sold within 30 days and 151 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 18.4% of the 10,216 shares held after it.
- 1 other insider sold within 30 days.
- 151 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hipp Mark sold about $153.3K of CRI on Mar 6, 2024; 1 other insider sold within 30 days and 151 funds added in the latest 13F quarter.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Dec 27, 2022.
- The trade is 15.1% of the 390,731 shares held after it.
- 2 other insiders sold within 30 days.
- 151 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman and CEO CASEY MICHAEL DENNIS sold about $4.4M of CRI on Dec 14, 2023, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 151 funds added in the latest 13F quarter.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Dec 27, 2022.
- The trade is 6.7% of the 449,870 shares held after it.
- 2 other insiders sold within 30 days.
- 151 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman and CEO CASEY MICHAEL DENNIS sold about $2.2M of CRI on Dec 14, 2023, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 151 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 9, 2022.
- The trade is 7.9% of the 42,783 shares held after it.
- 2 other insiders sold within 30 days.
- 151 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Sales D'Emilio Julie sold about $246.5K of CRI on Dec 8, 2023; 2 other insiders sold within 30 days and 151 funds added in the latest 13F quarter.41 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
151 funds bought in last quarter
more than 63% of Consumer Goods
Revenue
+1.9% year over year
below 51% of Consumer Goods
Margin
3.2% net margin
more than 61% of Consumer Goods
Buybacks
no share repurchases reported
Short interest
21.8% of the float short (float per yahoo 2026-10-26) · 5.1 days to cover · settled 2026-09-30
more than 98% of Consumer Goods
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CRI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+2.3%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CRI: institutional holders (13F)
13F holdings, latest reported quarter
5,824,048 sh
$239.7M
2,870,722 sh
$118.2M
2,269,347 sh
$93.4M
1,905,146 sh
$78.4M
1,564,269 sh
$64.4M
Congress trades in CRI
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CRI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CRI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
HARTFORD SMALL CAP VALUE FUND
$4.9M position · as of 2026-07-31
1.6%
PIMCO RAE US Small Fund
$50.3M position · as of 2026-06-30
1.3%
GMO U.S. Small Cap Value Fund
$525.8K position · as of 2026-05-31
1.2%
Easterly Snow Long/Short Opportunity Fund
$1.2M position · as of 2026-05-31
1.1%
Acquirers Small and Micro Deep Value ETF
$256.7K position · as of 2026-05-31
1.0%
Small Cap Portfolio
$3.4M position · as of 2026-06-30
0.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Michael
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2020
$7.3M
-$185.5K
$1.6M
-13%
-8%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 151 funds added last quarter. Each figure is a federal filing, dated the day it went public.
CRI financials
Revenue growth
+1.9%
XBRL, annual
Net margin
3.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.0B
four quarters, 2025-06-29 to 2026-07-04
Revenue, TTM CRI
| FY Jan 2026 | $2.9B |
| FY Dec 2024 | $2.8B |
| FY Dec 2023 | $2.9B |
| FY Dec 2022 | $3.2B |
| FY Jan 2022 | $3.5B |
| Jul 2026 | $615.5M |
| Apr 2026 | $681.1M |
| Jan 2026 | $925.5M |
| Sep 2025 | $757.8M |
| Jun 2025 | $585.3M |
| Mar 2025 | $629.8M |
| Dec 2024 | $859.7M |
| Sep 2024 | $758.5M |
At each fiscal year end
Single quarter
Net margin, TTM
+6.5%
net income over revenue, 2025-06-29 to 2026-07-04
Net margin, TTM CRI
| FY Jan 2026 | +3.2% |
| FY Dec 2024 | +6.5% |
| FY Dec 2023 | +7.9% |
| FY Dec 2022 | +7.8% |
| FY Jan 2022 | +9.7% |
| Jul 2026 | +17.1% |
| Apr 2026 | +2.1% |
| Jan 2026 | +6.9% |
| Sep 2025 | +1.5% |
| Jun 2025 | +0.1% |
| Mar 2025 | +2.5% |
| Dec 2024 | +7.2% |
| Sep 2024 | +7.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$293.0M
operating cash flow minus capex, 2025-06-29 to 2026-07-04
Free cash flow, TTM CRI
| FY Jan 2026 | $68.6M |
| FY Dec 2024 | $242.6M |
| FY Dec 2023 | $469.3M |
| FY Dec 2022 | $48.0M |
| FY Jan 2022 | $230.8M |
| Jul 2026 | $190.0M |
| Apr 2026 | -$543.0K |
| Jan 2026 | $247.6M |
| Sep 2025 | -$144.1M |
| Jun 2025 | $24.1M |
| Mar 2025 | -$59.0M |
| Dec 2024 | $270.9M |
| Sep 2024 | -$95.7M |
At each fiscal year end
Single quarter
Debt to equity
0.55x
long-term 2026-07-04 plus current 2023-04-01 (39 months older than the period end); equity 2026-07-04
Debt to equity CRI
| FY Jan 2026 | 0.61x |
| FY Dec 2024 | 0.58x |
| FY Dec 2023 | 0.59x |
| FY Dec 2022 | 0.77x |
| FY Jan 2022 | 1.04x |
| Jul 2026 | 0.55x |
| Apr 2026 | 0.61x |
| Jan 2026 | 0.61x |
| Sep 2025 | 0.58x |
| Jun 2025 | 0.58x |
| Mar 2025 | 0.59x |
| Dec 2024 | 0.58x |
| Sep 2024 | 0.60x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.59x
TTM operating cash flow over long-term 2026-07-04 plus current 2023-04-01 (39 months older than the period end)
Cash flow to debt CRI
| FY Jan 2026 | 0.22x |
| FY Dec 2024 | 0.60x |
| FY Dec 2023 | 1.06x |
| FY Dec 2022 | 0.14x |
| FY Jan 2022 | 0.27x |
| Jul 2026 | 0.59x |
| Apr 2026 | 0.31x |
| Jan 2026 | 0.22x |
| Sep 2025 | 0.30x |
| Jun 2025 | 0.40x |
| Mar 2025 | 0.55x |
| Dec 2024 | 0.60x |
| Sep 2024 | 0.67x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+20.7%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on equity CRI
| FY Jan 2026 | +10.3% |
| FY Dec 2024 | +21.8% |
| FY Dec 2023 | +28.3% |
| FY Dec 2022 | +28.6% |
| FY Jan 2022 | +36.0% |
| Jul 2026 | +20.7% |
| Apr 2026 | +10.2% |
| Jan 2026 | +10.3% |
| Sep 2025 | +10.5% |
| Jun 2025 | +16.3% |
| Mar 2025 | +19.3% |
| Dec 2024 | +21.8% |
| Sep 2024 | +28.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.5%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on assets CRI
| FY Jan 2026 | +3.7% |
| FY Dec 2024 | +7.7% |
| FY Dec 2023 | +9.7% |
| FY Dec 2022 | +8.9% |
| FY Jan 2022 | +10.3% |
| Jul 2026 | +7.5% |
| Apr 2026 | +3.8% |
| Jan 2026 | +3.7% |
| Sep 2025 | +3.7% |
| Jun 2025 | +5.6% |
| Mar 2025 | +7.1% |
| Dec 2024 | +7.7% |
| Sep 2024 | +9.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+22.0%
operating income after a 21.1% effective tax rate, over long-term 2026-07-04 plus current 2023-04-01 (39 months older than the period end) plus average of 2025-06-28 and 2026-07-04 minus cash
Return on invested capital CRI
| FY Jan 2026 | +11.5% |
| FY Dec 2024 | +21.2% |
| FY Dec 2023 | +24.0% |
| FY Dec 2022 | +33.6% |
| FY Jan 2022 | +43.2% |
| Jul 2026 | +22.0% |
| Apr 2026 | +11.1% |
| Jan 2026 | +11.5% |
| Sep 2025 | +9.6% |
| Jun 2025 | +15.2% |
| Mar 2025 | +17.4% |
| Dec 2024 | +21.2% |
| Sep 2024 | +21.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+13.9%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-07-04 minus current liabilities
Return on capital employed CRI
| FY Jan 2026 | +7.2% |
| FY Dec 2024 | +13.4% |
| FY Dec 2023 | +17.1% |
| FY Dec 2022 | +17.3% |
| FY Jan 2022 | +19.6% |
| Jul 2026 | +13.9% |
| Apr 2026 | +7.4% |
| Jan 2026 | +7.2% |
| Sep 2025 | +7.4% |
| Jun 2025 | +10.1% |
| Mar 2025 | +11.9% |
| Dec 2024 | +13.4% |
| Sep 2024 | +16.4% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
5.93x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-07-04
P/E, trailing CRI
| FY Jan 2026 | 13.07x |
| FY Dec 2024 | 10.61x |
| FY Dec 2023 | 11.98x |
| FY Dec 2022 | 11.77x |
| FY Jan 2022 | 12.96x |
| Jul 2026 | 7.58x |
| Apr 2026 | 14.36x |
| Jan 2026 | 13.07x |
| Sep 2025 | 11.82x |
| Jun 2025 | 7.97x |
| Mar 2025 | 8.95x |
| Dec 2024 | 10.61x |
| Sep 2024 | 10.58x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.1B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term 2026-07-04 plus current 2023-04-01 (39 months older than the period end), minus cash 2026-07-04
Enterprise value CRI
| FY Jan 2026 | $1.3B |
| FY Dec 2024 | $2.0B |
| FY Dec 2023 | $2.9B |
| FY Dec 2022 | $3.3B |
| FY Jan 2022 | $4.3B |
| Jul 2026 | $1.4B |
| Apr 2026 | $1.4B |
| Jan 2026 | $1.3B |
| Sep 2025 | $1.4B |
| Jun 2025 | $1.3B |
| Mar 2025 | $1.6B |
| Dec 2024 | $2.0B |
| Sep 2024 | $2.7B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+25.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield CRI
| FY Jan 2026 | +5.7% |
| FY Dec 2024 | +12.4% |
| FY Dec 2023 | +17.0% |
| FY Dec 2022 | +1.7% |
| FY Jan 2022 | +5.4% |
| Jul 2026 | +19.6% |
| Apr 2026 | +9.7% |
| Jan 2026 | +5.7% |
| Sep 2025 | +8.6% |
| Jun 2025 | +12.8% |
| Mar 2025 | +15.2% |
| Dec 2024 | +12.4% |
| Sep 2024 | +11.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.14x
P/E over trailing EPS growth of 42%: four quarters to 2026-07-04 against the four to 2025-06-28
PEG, trailing CRI
| FY Jan 2026 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | 0.06x |
| Jul 2026 | 0.18x |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 0.68x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-01 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.9B | $3.2B |
| Gross profit | $1.3B | $1.4B | $1.4B | $1.5B |
| Operating income | $143.9M | $254.7M | $323.4M | $379.2M |
| Net income | $91.8M | $185.5M | $232.5M | $250.0M |
| EPS (diluted) | 2.53 | 5.12 | 6.24 | 6.34 |
| Operating cash flow | $122.3M | $298.8M | $529.1M | $88.4M |
| Cash | $487.1M | $412.9M | $351.2M | $211.7M |
| Long-term debt | $567.2M | $498.1M | $497.4M | $616.6M |
| Buybacks | $0 | $50.5M | $100.0M | $299.7M |
| Dividends paid | $56.4M | $116.2M | $112.0M | $118.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
CRI Stock Sonar score 5/7 axes
Find similar shapesCompareCRI ranks highest on profitability (71st percentile) and institutional and government (63rd), and lowest on risk and compliance (47th), among Consumer Goods peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
